Thin Film Drug Manufacturing Market Trends, 2016-2024

Thin Film Drug Manufacturing Market (Product - Oral Thin Film (Sublingual Film and Fully Dissolving Dental/Buccal Film), and Transdermal Thin Film; Disease Indication - Schizophrenia, Migraine, Opioid Dependence, and Nausea and Vomiting; Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies, and E-Commerce) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024

Global Thin Film Drug Manufacturing Market: Snapshot

The thin film drugs were recorded with high market acceptance due to its ease of application and high effectiveness. Moreover, developed economies such as the U.S. and countries in Europe recorded significant sale of thin film drugs. Thin film drugs achieve the desired therapeutic results. Therefore, they have gained attention in the market as a potential treatment option. According to the research report, the global thin film drug manufacturing market is expected to be worth US$15,984.3 mn by the end of 2024 from US$7,337.8 mn in 2015. During the forecast years of 2016 and 2024, the global market is projected to exhibit a CAGR of 9.0%.

Demand for thin film drugs is increasing globally, leading to considerable research and development activities in the segment. The Journal of Controlled Release 2015 stated the market for oral thin film products exists with around 10 prescription products and around 29 such thin film products under clinical trials. Thus, the thin film drug manufacturing market is anticipated to expand considerably during the forecast period.

thin film drug manufacturing market

 

Oral Thin Films to Remain Popular due to Ease of Handling

On the basis of product type, the global thin film drug manufacturing market is segmented into oral thin film, transdermal thin film, and others such as ocular thin film among others. The report indicates that the oral thin film segment will be the most promising one as it comes with maximum advantages. These films deliver drugs through the oral mucosa and are known for ease of transportation, skipping the hepatic first pass effect, convenience of handling, and quick onset of action. In light of these benefits, the oral thin film segment is likely to surge at a significant CAGR of 18.3% between 2016 and 2024. Soaring revenue of this segment is attributable to the growing number of clinical trials and higher number of prescription products. On the other hand, the transdermal thin film segment is also poised to emerge with a substantial share in the global market by the end of the forecast period.

North America Emerges as Leading Regional Market

By geography, global thin film drug manufacturing market has been segmented into North America, Europe, Asia Pacific, Latin America, the and Middle East and Africa. In 2016, North America and Europe accounted for the largest share of the thin film drug manufacturing market. The U.S. dominated the thin film drug manufacturing market in North America, accounting for around 85.3% share in 2016. This dominance is majorly due factors such technological advancements in pharmaceutical research with rising demand of novel drug delivery. The extensive investments in research and development are also likely to benefit the regional market. However, Europe is saturated and growing at slow steady rate while Asia Pacific is anticipated to witness the fast growth during the forecast period with major contribution of countries such as India, Japan and China. New product launches with broaden applications, favorable regulations, and growing awareness are likely to drive the market in Asia Pacific during the forecast period.

Some of the key players in the global thin film drug manufacturing market are Pfizer, Inc., Novartis AG, Wolters Kluwer, Solvay, Allergan plc. Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp. The global thin film drug manufacturing market is dominated only by few players, which makes the competitive landscape highly consolidated.

The global thin film drug manufacturing market is segmented as follows:

by Product Type

  • Oral Thin Film
    • Sublingual Film
    • Fully Dissolving Dental/Buccal Film
  • Transdermal Thin Film
  • Others (ocular thin film, etc.)

by Disease Indication

  • Schizophrenia
  • Migraine
  • Opioid Dependence
  • Nausea & Vomiting
  • Others

by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of the Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arebia
    • UAE
    • Rest of MEA

Frequently Asked Questions

What is the total market worth of thin film drug manufacturing market?

Thin film drug manufacturing market is projected to reach US$ 15.984 billion by 2024

What is the anticipated CAGR of the thin film drug manufacturing market in the forecast period?

Thin film drug manufacturing market is anticipated to expand at a CAGR of 9.0% during the forecast period

What are the key driving factors for the growth of the thin film drug manufacturing market?

Thin film drug manufacturing market is driven by rising demand of novel drug delivery, technological advancements in pharmaceutical research, new product launches with broaden applications, and growing awareness

Which is the rising prominent segment in the thin film drug manufacturing market?

Oral thin film segment will be the most promising one as it comes with maximum advantages

Who are the key players in the global thin film drug manufacturing market?

Top Key players in thin film drug manufacturing market are Pfizer, Inc., Novartis AG, Wolters Kluwer, Solvay, Allergan plc. Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp

    1. Preface 
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology 

    3. Executive Summary

    4. Market Overview
         4.1. Introduction
                4.1.1. Product Definition
                4.1.2. Industry Evolution / Developments
         4.2. Overview
         4.3. Key Market Indicators
         4.4. Market Dynamics
                4.4.1. Drivers
                4.4.2. Restraints
                4.4.3. Opportunity 
         4.5. Global Thin Film Drug Manufacturing  Analysis and Forecasts, 2016–2024
         4.6. Thin Film Drug Manufacturing  - Global Supply Demand Scenario
         4.7. Porter’s Five Force Analysis
         4.8. Value Chain Analysis
         4.9. Market Outlook

    5.  Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Product
         5.1. Introduction & Definition
         5.2. Key Findings / Developments
         5.3. Key Trends
         5.4. Market Value Forecast By Product, 2016–2024
                5.4.1. Oral Thin Film
                         5.4.1.1. Sublingual film
                         5.4.1.2. Fully dissolving dental/ buccal film
                5.4.2. Transdermal Thin Film
                5.4.3. Others
         5.5. Product  Comparison Matrix
         5.6. Market Attractiveness By Product
         5.7. Oral Thin Film Drugs : Key market insights
                5.7.1. Pipeline Analysis
                5.7.2. Technology Insights
                5.7.3. Key Product Insights

    6. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Distribution Channel
         6.1. Introduction & Definition
         6.2. Key Findings
         6.3. Market Value Forecast By Distribution Channel, 2016–2024
                6.3.1. Hospital Pharmacies
                6.3.2.  Drug Stores
                6.3.3. Retail Pharmacies
                6.3.4. E- Commerce
         6.4. Distribution Channel  Comparison Matrix
         6.5. Market Attractiveness By Distribution Channel 

    7. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Disease Indication
         7.1. Introduction & Definition
         7.2. Key Findings
         7.3. Key Trends
         7.4. Market Value Forecast By Disease Indication, 2016–2024
                7.4.1. Schizophrenia
                7.4.2. Migraine
                7.4.3. Opioid Dependence
                7.4.4. Nausea & Vomiting
                7.4.5. Others
         7.5. Disease Indication Comparison Matrix
         7.6. Market Attractiveness By Disease Indication

    8. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Region
         8.1. Introduction & Definition
         8.2. Key Findings
         8.3. Market Value Forecast By Region
                8.3.1. North America
                8.3.2. Latin America 
                8.3.3. Asia Pacific
                8.3.4. Europe
                8.3.5. Middle East & Africa
         8.4. Market Attractiveness By Country/Region

    9. North America Thin Film Drug Manufacturing  Analysis and Forecast
         9.1. Introduction
         9.2. Market Value Forecast By Product, 2016–2024
                9.2.1. Oral Thin Film
                         9.2.1.1. Sublingual film
                         9.2.1.2. Fully dissolving dental/ buccal film
                9.2.2. Transdermal Thin Film
                9.2.3. Others (Ocular Thin Film, etc.)
         9.3. Market Value Forecast By Distribution Channel, 2016–2024
                9.3.1. Hospital Pharmacies
                9.3.2. Drug Stores
                9.3.3. Retail Pharmacies
                9.3.4. E- Commerce
         9.4. Market Value Forecast By Disease Indication, 2016–2024
                9.4.1. Schizophrenia
                9.4.2. Migraine
                9.4.3. Opioid Dependence
                9.4.4. Nausea & Vomiting
                9.4.5. Others
         9.5. Market Value Forecast By Country, 2016–2024
                9.5.1. U.S.
                9.5.2. Canada
         9.6. Market Attractiveness Analysis 
                9.6.1. By Product
                9.6.2. By Distribution Channel
                9.6.3. By Disease Indication
                9.6.4. By Country

    10. Latin America Thin Film Drug Manufacturing  Analysis and Forecast
         10.1. Introduction
         10.2. Market Value Forecast By Product, 2016–2024
                10.2.1. Oral Thin Film
                         10.2.1.1. Sublingual film
                         10.2.1.2. Fully dissolving dental/ buccal film
                10.2.2. Transdermal Thin Film
                10.2.3. Others (Ocular Thin Film, etc.)
         10.3. Market Value Forecast By Distribution Channel, 2016–2024
                10.3.1. Hospital Pharmacies
                10.3.2. Drug Stores
                10.3.3. Retail Pharmacies
                10.3.4. E- Commerce
         10.4. Market Value Forecast By Disease Indication, 2016–2024
                10.4.1. Schizophrenia
                10.4.2. Migraine
                10.4.3. Opioid Dependence
                10.4.4. Nausea & Vomiting
                10.4.5. Others
         10.5. Market Value Forecast By Country, 2016–2024
                10.5.1. Brazil
                10.5.2. Mexico
                10.5.3. Rest of Latin America
         10.6. Market Attractiveness Analysis 
                10.6.1. By Product
                10.6.2. By Distribution Channel
                10.6.3. By Disease Indication
                10.6.4. By Country

    11. Asia Pacific Thin Film Drug Manufacturing  Analysis and Forecast
         11.1. Introduction
         11.2. Market Value Forecast By Product, 2016–2024
                11.2.1. Oral Thin Film
                         11.2.1.1. Sublingual film
                         11.2.1.2. Fully dissolving dental/ buccal film
                11.2.2. Transdermal Thin Film
                11.2.3. Others (Ocular Thin Film, etc.)
         11.3. Market Value Forecast By Distribution Channel, 2016–2024
                11.3.1. Hospital Pharmacies
                11.3.2. Drug Stores
                11.3.3. Retail Pharmacies
                11.3.4. E- Commerce
         11.4. Market Value Forecast By Disease Indication, 2016–2024
                11.4.1. Schizophrenia
                11.4.2. Migraine
                11.4.3. Opioid Dependence
                11.4.4. Nausea & Vomiting
                11.4.5. Others
         11.5. Market Value Forecast By Country, 2016–2024
                11.5.1. Japan
                11.5.2. India
                11.5.3. China
                11.5.4. Rest Of Asia Pacific
         11.6. Market Attractiveness Analysis 
                11.6.1. By Product
                11.6.2. By Distribution Channel
                11.6.3. By Disease Indication
                11.6.4. By Country

    12.  Europe Thin Film Drug Manufacturing  Analysis and Forecast
         12.1. Introduction
         12.2. Market Value Forecast By Product, 2016–2024
                12.2.1. Oral Thin Film
                         12.2.1.1. Sublingual film
                         12.2.1.2. Fully dissolving dental/ buccal film
                12.2.2. Transdermal Thin Film
                12.2.3. Others (Ocular Thin Film, etc.)
         12.3. Market Value Forecast By Distribution Channel, 2016–2024
                12.3.1. Hospital Pharmacies
                12.3.2. Drug Stores
                12.3.3. Retail Pharmacies
                12.3.4. E- Commerce
         12.4. Market Value Forecast By Disease Indication, 2016–2024
                12.4.1. Schizophrenia
                12.4.2. Migraine
                12.4.3. Opioid Dependence
                12.4.4. Nausea & Vomiting
                12.4.5. Others
         12.5. Market Value Forecast By Country, 2016–2024
                12.5.1. France
                12.5.2. Germany 
                12.5.3. Italy
                12.5.4. Spain
                12.5.5. Russia
                12.5.6. Rest Of Europe
         12.6. Market Attractiveness Analysis 
                12.6.1. By Product
                12.6.2. By Distribution Channel
                12.6.3. By Disease Indication
                12.6.4. By Country

    13. Middle East & Africa Thin Film Drug Manufacturing  Analysis and Forecast
         13.1.  Introduction
         13.2. Market Value Forecast By Product, 2016–2024
                13.2.1. Oral Thin Film
                         13.2.1.1. Sublingual film
                         13.2.1.2. Fully dissolving dental/ buccal film
                13.2.2. Transdermal Thin Film
                13.2.3. Others (Ocular Thin Film, etc.)
         13.3. Market Value Forecast By Distribution Channel, 2016–2024
                13.3.1. Hospital Pharmacies
                13.3.2. Drug Stores
                13.3.3. Retail Pharmacies
                13.3.4. E- Commerce
         13.4. Market Value Forecast By Disease Indication, 2016–2024
                13.4.1. Schizophrenia
                13.4.2. Migraine
                13.4.3. Opioid Dependence
                13.4.4. Nausea & Vomiting
                13.4.5. Others
         13.5. Market Value Forecast By Country, 2016–2024
                13.5.1. South Africa
                13.5.2. Saudi Arabia
                13.5.3. UAE
                13.5.4. Rest of Middle East & Africa
         13.6. Market Attractiveness Analysis 
                13.6.1. By Product
                13.6.2. By Distribution Channel
                13.6.3. By Disease Indication
                13.6.4. By Country

    14. Competition Landscape
         14.1. Market Player – Competition Matrix (By Tier and Size of companies)
         14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
                14.2.1. ZIM Laboratories Limited
                         14.2.1.1. Company Details
                         14.2.1.2. Business Overview
                         14.2.1.3. Financial Overview
                         14.2.1.4. Strategic Overview
                         14.2.1.5. SWOT Analysis
                14.2.2. Indivior plc.
                         14.2.2.1. Company Details
                         14.2.2.2. Business Overview
                         14.2.2.3. Financial Overview
                         14.2.2.4. Strategic Overview
                         14.2.2.5. SWOT Analysis
                14.2.3. MonoSol Rx Allergan plc.
                         14.2.3.1. Company Details
                         14.2.3.2. Business Overview
                         14.2.3.3. Financial Overview
                         14.2.3.4. Strategic Overview
                         14.2.3.5. SWOT Analysis
                14.2.4. Sumitomo Dainippon Pharma Co., Ltd.
                         14.2.4.1. Company Details
                         14.2.4.2. Business Overview
                         14.2.4.3. Financial Overview
                         14.2.4.4. Strategic Overview
                         14.2.4.5. SWOT Analysis
                14.2.5. IntelGenx Corp
                         14.2.5.1. Company Details
                         14.2.5.2. Business Overview
                         14.2.5.3. Financial Overview
                         14.2.5.4. Strategic Overview
                         14.2.5.5. SWOT Analysis
                14.2.6. Pfizer, Inc.
                         14.2.6.1. Company Details
                         14.2.6.2. Business Overview
                         14.2.6.3. Financial Overview
                         14.2.6.4. Strategic Overview
                         14.2.6.5. SWOT Analysis
                14.2.7. Novartis AG
                         14.2.7.1. Company Details
                         14.2.7.2. Business Overview
                         14.2.7.3. Financial Overview
                         14.2.7.4. Strategic Overview
                         14.2.7.5. SWOT Analysis
                14.2.8. Allergan plc.
                         14.2.8.1. Company Details
                         14.2.8.2. Business Overview
                         14.2.8.3. Financial Overview
                         14.2.8.4. Strategic Overview
                         14.2.8.5. SWOT Analysis
                14.2.9. NAL Pharma
                         14.2.9.1. Company Details
                         14.2.9.2. Business Overview
                         14.2.9.3. Financial Overview
                         14.2.9.4. Strategic Overview
                         14.2.9.5. SWOT Analysis
                14.2.10. Wolters Kluwer
                         14.2.10.1. Company Details
                         14.2.10.2. Business Overview
                         14.2.10.3. Financial Overview
                         14.2.10.4. Strategic Overview
                         14.2.10.5. SWOT Analysis
                14.2.11. Solvay
                         14.2.11.1. Company Details
                         14.2.11.2. Business Overview
                         14.2.11.3. Financial Overview
                         14.2.11.4. Strategic Overview
                         14.2.11.5. SWOT Analysis

    List of Tables

    Table 01: Global Opportunity for Oral Thin Film Drugs Market (Addressable Market), Revenue (US$ Bn), Forecast 2016–2024, by Product Type
    Table 02: Global Opportunity for Oral Thin Film Drugs Market (Addressable Market), Revenue (US$ Bn), Forecast 2016-2024, by Region
    Table 03: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type,2014–2024
    Table 04: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type,2014–2024
    Table 05: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
    Table 06: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
    Table 07: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Region, 2014–2024
    Table 08: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
    Table 09: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
    Table 10: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
    Table 11: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
    Table 12: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
    Table 13: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
    Table 14: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
    Table 15: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
    Table 16: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
    Table 17: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
    Table 18: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
    Table 19: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
    Table 20: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
    Table 21: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
    Table 22: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
    Table 23: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
    Table 24: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
    Table 25: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
    Table 26: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
    Table 27: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
    Table 28: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
    Table 29: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
    Table 30: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
    Table 31: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
    Table 32: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel

    List of Figures

    Figure 01: Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2016–2024
    Figure 03: Market Value Share (%), by Disease Indication (2015)
    Figure 05: Market Value Share (%), by Region (2015)
    Figure 02: Market Value Share (%), by Product Type (2015)
    Figure 04: Market Value Share (%), by Distribution Channel (2015)
    Figure 06: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
    Figure 07: Global Oral Thin Film Drug Market Revenue (US$ Mn), 2014–2024
    Figure 08: Global Transdermal Thin Film Drug Market Revenue (US$ Mn), 2014–2024
    Figure 09: Global others (ocular thin film, etc.) Market Revenue (US$ Mn), 2014–2024
    Figure 10: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2014–2024
    Figure 11: Oral Thin Film Drug Manufacturing Market, Pipeline Analysis 2015
    Figure 12: Oral Thin Film Drug Manufacturing Market, by Technology
    Figure 13: Global Sales of Major OTF Products (US$ Thousand), 2014
    Figure 14: Total SUBOXONE Film Sales (US$ Mn), 2010–2014
    Figure 15: Total Onsolis & Breakyl Sales (US$ Thousand), 2011–2014
    Figure 16: Total Fentanyl Product Sales (US$ Mn), 2010–2014
    Figure 17: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
    Figure 18: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Schizophrenia, 2014–2024
    Figure 19: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Migraine, 2014–2024
    Figure 20: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Opioid Dependence, 2014–2024
    Figure 21: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Nausea & Vomiting, 2014–2024
    Figure 22: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Others, 2014–2024
    Figure 23: Global Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016-2024
    Figure 24: Number of oral thin ?lm drugs by disease indication (out of total identified drugs at different drug development stages), 2015
    Figure 25: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
    Figure 26: Thin Film Drug Manufacturing Market, by Hospital Pharmacies, Revenue (US$ Mn), 2014–2024
    Figure 27: Thin Film Drug Manufacturing Market, by Drug Store, Revenue (US$ Mn), 2014–2024
    Figure 28: Thin Film Drug Manufacturing Market, by Retail Pharmacies, Revenue (US$ Mn), 2014–2024
    Figure 29: Thin Film Drug Manufacturing Market by E-Commerce, Revenue (US$ Mn), 2014–2024
    Figure 30: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2014–2024
    Figure 31: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Region, 2016 and 2024
    Figure 32: North America Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
    Figure 33: Europe Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
    Figure 34: Latin America Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
    Figure 35: Asia Pacific Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
    Figure 36: Middle East & Africa Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
    Figure 37: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Region, 2014–2024
    Figure 38: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
    Figure 39: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
    Figure 40: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
    Figure 41: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
    Figure 42: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
    Figure 43: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
    Figure 44: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
    Figure 45: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
    Figure 46: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
    Figure 47: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
    Figure 48: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
    Figure 49: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
    Figure 50: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
    Figure 51: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
    Figure 52: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
    Figure 53: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
    Figure 54: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
    Figure 55: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
    Figure 56: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
    Figure 57: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
    Figure 58: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
    Figure 59: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
    Figure 60: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
    Figure 61: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
    Figure 62: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
    Figure 63: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
    Figure 64: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
    Figure 65: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
    Figure 66: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
    Figure 67: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
    Figure 68: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
    Figure 69: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
    Figure 70: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
    Figure 71: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
    Figure 72: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
    Figure 73: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
    Figure 74: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
    Figure 75: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
    Figure 76: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
    Figure 77: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
    Figure 78: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
    Figure 79: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
    Figure 80: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
    Figure 81: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
    Figure 82: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024

Copyright © Transparency Market Research, Inc. All Rights reserved

We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.

By clicking "Accept All", you consent to our use of cookies. Privacy Policy